Ganapathy; Vadivel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ganapathy; Vadivel.The latest application filed is for "methods of treating sickle cell disease and related disorders using fumaric acid esters".

Company Profile

2.7.16

Ganapathy; Vadivel - Martinez GA
Ganapathy; Vadivel - Lubbock TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters App 20210113512 - Ganapathy; Vadivel ; et al.	2021-04-22
Methods of treating sickle cell disease and related disorders using fumaric acid esters Grant 10,813,905 - Ganapathy , et al. October 27, 2	2020-10-27
Carbidopa for the treatment of cancer Grant 10,064,834 - Ganapathy , et al. September 4, 2	2018-09-04
Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters App 20170333378 - Ganapathy; Vadivel ; et al.	2017-11-23
Carbidopa for the Treatment of Cancer App 20170319527 - Ganapathy; Vadivel ; et al.	2017-11-09
Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters App 20160074355 - Ganapathy; Vadivel ; et al.	2016-03-17
Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters App 20140171504 - Ganapathy; Vadivel	2014-06-19
Atb(0,+) Amino Acid Transporter As A Drug Target For Treatment Of Estrogen Receptor-positive Breast Cancer App 20140024663 - GANAPATHY; VADIVEL ; et al.	2014-01-23
Inhibitors Of The Atb(0,+) Transporter And Uses Thereof App 20130230512 - GANAPATHY; VADIVEL ; et al.	2013-09-05
Prodrugs of short-chain fatty acids and treatment methods Grant 8,518,989 - Ganapathy , et al. August 27, 2	2013-08-27
Alpha-methyl-tryptophan As An Inhibitor Of Indoleamine Dioxygenase App 20130142815 - Ganapathy; Vadivel	2013-06-06
Inhibitors of the ATB(0,+) transporter and uses thereof Grant 8,436,039 - Ganapathy , et al. May 7, 2	2013-05-07
Compositions comprising a GPR109 ligand for treating disorders of the digestive tract and/or cancer Grant 8,309,534 - Ganapathy , et al. November 13, 2	2012-11-13
Prodrugs Of Short-chain Fatty Acids And Treatment Methods App 20110245339 - GANAPATHY; VADIVEL ; et al.	2011-10-06
Inhibitors Of The Atb(0,+) Transporter And Uses Thereof App 20100305184 - Ganapathy; Vadivel ; et al.	2010-12-02
Compositions Comprising a GPR109 Ligand For Treating Disorders of the Digestive Tract and/or Cancer App 20100137236 - Ganapathy; Vadivel ; et al.	2010-06-03
Prodrugs of Short-Chain Fatty Acids and Treatment Methods App 20090123388 - Ganapathy; Vadivel ; et al.	2009-05-14
Na+ and CI-coupled transport system for endogenous opioid peptides App 20060019241 - Ganapathy; Vadivel ; et al.	2006-01-26
NaCT as a target for lifespan expansion and weight reduction App 20050095240 - Ganapathy, Vadivel ; et al.	2005-05-05
Use of amino acid transporter atbo,+ as a delivery system for drugs and prodrugs App 20040142317 - Ganapathy, Vadivel ; et al.	2004-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.